Treatment Outcome of Locally Advanced Non-small Cell Lung Cancer Patients Who Received Concurrent Chemoradiotherapy with Weekly Paclitaxel
![]() |
Kim, Su-Zy
(Lung Cancer Center, St. Vincent's Hospital, Departments of Radiation Oncology, The Catholic University of Korea College of Medicine)
Shim, Byoung-Yong (Lung Cancer Center, St. Vincent's Hospital, Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Chi-Hong (Lung Cancer Center, St. Vincent's Hospital, Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Song, So-Hyang (Lung Cancer Center, St. Vincent's Hospital, Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Ahn, Meyung-Im (Lung Cancer Center, St. Vincent's Hospital, Departments of Diagnostic Radiology, The Catholic University of Korea College of Medicine) Cho, Deog-Gon (Lung Cancer Center, St. Vincent's Hospital, Departments of Chest Surgery, The Catholic University of Korea College of Medicine) Cho, Kyu-Do (Lung Cancer Center, St. Vincent's Hospital, Departments of Chest Surgery, The Catholic University of Korea College of Medicine) Yoo, Jin-Young (Lung Cancer Center, St. Vincent's Hospital, Departments of Pathology, The Catholic University of Korea College of Medicine) Kim, Hoon-Kyo (Lung Cancer Center, St. Vincent's Hospital, Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Sung-Whan (Lung Cancer Center, St. Vincent's Hospital, Departments of Radiation Oncology, The Catholic University of Korea College of Medicine) |
1 | Johnson DH, Einhorn LH, Bartolucci A, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990;113:33-38 DOI ScienceOn |
2 | Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996;88:1210-1215 DOI ScienceOn |
3 | Sause W, Kolesar P, Taylor S IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000;117:358-364 DOI ScienceOn |
4 | Herrmann T, Knorr A, Dorner K. The RTOG/EORTC classification criteria for early and late radiation reactions. Radiobiol Radiother (Berl) 1987;28:519-528 |
5 | Bae S, Kim KC, Lee S, et al. Efficacy of weekly paclitaxel and concurrent radiation therapy for locally advanced non- small cell lung cancer. Korean J Med 2005;69:379-386 |
6 | Bae KW, Song TH, Yang JY, et al. Concurrent chemoradiation with weekly paclitaxel in locally advanced non-small cell lung cancer. Tuberc Respir Dis 2004;57:351-357 DOI |
7 | Cox JD, Pajak TF, Herskovic A, Urtasun R, Podolsky WJ, Seydel HG. Five-year survival after hyperfractionated radiation therapy for non-small cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08. Am J Clin Oncol 1991;14:280-284 DOI ScienceOn |
8 | Choy H, Safran H, Akerley W, Graziano SL, Bogart JA, Cole BF. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clin Cancer Res 1998;4:1931-1936 |
9 | Choy H, Akerley W, Safran H, et al. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small cell lung cancer. J Clin Oncol 1994;12:2682-2686 DOI |
10 | Petrovich Z, Stanley K, Cox JD, Paig C. Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial. Cancer 1981;48:1335-1340 DOI ScienceOn |
11 | Kim YS, Yoon SM, Choi EK, et al. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005;62:76-81 DOI ScienceOn |
12 | Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 1995; 55:3564-3568 |
13 | Gandara DR, Chansky K, Albain KS, et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol 2003;21:2004-2010 DOI ScienceOn |
14 | Chang AY, Kim K, Glick J, Anderson T, Karp D, Johnson D. Phase II study of taxol, merbarone and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst 1993;85:388-394 DOI |
15 | Curran WJ, Scott C, Langer C, et al. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): initial report of Radiation Therapy Oncology Group (RTOG) 9410 [Abstract]. Proc Am Soc Clin Oncol 2000;19:1819 |
16 | NCI CTC v.2.0. http://ctep.cancer.gov/reporting/ctc.html |
17 | Kelly K, Gaspar LE, Chansky KS, et al. SWOG 0023: a randomized phase III trial of cisplatin/etoposide (PE) plus radiation therapy followed by consolidation docetaxel then maintenance therapy with gefitinib or placebo in patients with locally advanced unresectable stage III non small cell lung cancer. Lung Cancer. 2005;49(suppl 2):S64 |
18 | Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-2699 DOI |
19 |
Shim BY, Kim CH, Song SH, et al. The safety and efficacy of second-line single docetaxel (75 mg/ |
20 | Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 1996;88: 1308-1314 DOI ScienceOn |
21 | Murphy WK, Fossella FV, Winn RJ, et al. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer. J Natl Cancer Inst 1993;85:384-388 DOI ScienceOn |
![]() |